Theory of Mind in normal ageing and neurodegenerative pathologies

J Kemp, O Després, F Sellal, A Dufour - Ageing research reviews, 2012 - Elsevier
This paper reviews findings in three subcomponents of social cognition (ie, Theory of Mind,
facial emotion recognition, empathy) during ageing. Changes over time in social cognition …

[HTML][HTML] Neurologic manifestations associated with COVID-19: a multicentre registry

…, C Roos, J Saison, N Sayre, N Sedillot, F Sellal… - Clinical Microbiology …, 2021 - Elsevier
Objectives To provide an overview of the spectrum, characteristics and outcomes of neurologic
manifestations associated with severe acute respiratory syndrome coronavirus 2 (SARS-…

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia

…, AM Bernard, M Vercelletto, C Magne, F Sellal… - Brain, 2006 - academic.oup.com
We conducted a French multicentric cross-sectional study to describe in detail the demographic,
neurological and behavioural characteristics of the frontal variant of frontotemporal …

Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients

V Wolff, V Lauer, O Rouyer, F Sellal, N Meyer, JS Raul… - Stroke, 2011 - Am Heart Assoc
Background and Purpose— Our objective was to evaluate the relationship between cannabis
use and ischemic stroke in a young adult population. Methods— Forty-eight consecutive …

Progranulin null mutations in both sporadic and familial frontotemporal dementia

…, M Van den Broeck, B Dubois, F Sellal… - Human …, 2007 - Wiley Online Library
Frontotemporal dementia (FTD) is the second most frequent type of neurodegenerative
dementias. Mutations in the progranulin gene (GRN, PGRN) were recently identified in FTDU‐17, …

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

…, H Vespignani, A Campanella, F Sellal… - The Lancet …, 2014 - thelancet.com
Background Creutzfeldt-Jakob disease (CJD) is a fatal, untreatable prion encephalopathy.
Previous studies showed that doxycycline is effective in in-vitro and in-vivo models of disease, …

[HTML][HTML] Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

…, G Abitbol, N Schwald, C Hommet, F Sellal… - Alzheimer's & …, 2018 - Elsevier
Introduction Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD)
process yields conflicting results. The objective of the study was to assess plasma levels of Aβ …

Glial fibrillary acidic protein autoimmunity: a French cohort study

…, T De Broucker, L Kremer, P Kerschen, F Sellal… - Neurology, 2022 - AAN Enterprises
Background and Objectives To report the clinical, biological, and imaging features and
clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) …

APP mutations in cerebral amyloid angiopathy with or without cortical calcifications: report of three families and a literature review

F Sellal, D Wallon, L Martinez-Almoyna… - Journal of …, 2017 - content.iospress.com
Background: Specific APP mutations cause cerebral amyloid angiopathy (CAA) with or
without Alzheimer’s disease (AD). Objective: We aimed at reporting APP mutations associated …

The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers

…, O Moreaud, A Gabelle, F Sellal… - Journal of …, 2012 - content.iospress.com
We describe 56 novel autosomal dominant early-onset Alzheimer disease (ADEOAD) families
with PSEN1, PSEN2, and AβPP mutations or duplications, raising the total of families with …